Byline / Photo Credit: Reporter Hsin-Lu Yeh, Photo Center / Hsinchu News Desk

https://video.udn.com/embed/news/1310699

U-NEURON Biomedical Co., Ltd. officially inaugurated Taiwan’s first “Exosome R&D Pilot Manufacturing Center” at the Hsinchu Biomedical Science Park. The facility integrates exosome research and development, manufacturing, efficacy validation, and translational applications, targeting the regenerative aesthetics, skincare, and healthcare industries.

U-NEURON Chairman Dr. Frank Chien stated that the company’s core operations focus on two main directions: novel drug development, and skincare and healthcare products. Using fetal stem cells derived from amniotic fluid as its core platform, U-NEURON is advancing stem cell and exosome drug development for erectile dysfunction and dry eye syndrome.

 

Evergreen Biomedical Co., Ltd. opened Taiwan's first "Exosome Research and Leading Manufacturing Center" at the Zhubei Biomedical Park in the morning...
Photo / Hsin-Lu Yeh

 

Evergreen Biomedical Co., Ltd. opened Taiwan's first "Exosome Research and Leading Manufacturing Center" at the Zhubei Biomedical Park in the morning...
U-NEURON Biomedical Co., Ltd. officially inaugurated Taiwan’s first “Exosome R&D Pilot Manufacturing Center” at the Hsinchu Biomedical Science Park this morning. U-NEURON Chairman Dr. Frank Chien (6th from right), Deputy Minister of Economic Affairs Ho Chin-tsang (6th from left), and distinguished guests join the launch ceremony. Photo / Hsin-Lu Yeh
U-NEURON Biomedical Co., Ltd. officially inaugurated Taiwan’s first “Exosome R&D Pilot Manufacturing Center” at the Hsinchu Biomedical Science Park this morning, integrating exosome R&D, manufacturing, efficacy validation, and translational applications to address the regenerative aesthetics, skincare, and healthcare markets. Photo / Hsin-Lu Yeh